GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnGes Inc (STU:AJW) » Definitions » Other Current Receivables

AnGes (STU:AJW) Other Current Receivables : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is AnGes Other Current Receivables?

AnGes's Other Current Receivables for the quarter that ended in Dec. 2024 was €0.00 Mil.


AnGes Other Current Receivables Historical Data

The historical data trend for AnGes's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnGes Other Current Receivables Chart

AnGes Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AnGes Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AnGes Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


AnGes Other Current Receivables Related Terms

Thank you for viewing the detailed overview of AnGes's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


AnGes Business Description

Industry
Traded in Other Exchanges
Address
7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.

AnGes Headlines

No Headlines